RU2496787C2 - Пептиды эпитопов mybl2 и содержащие их вакцины - Google Patents

Пептиды эпитопов mybl2 и содержащие их вакцины Download PDF

Info

Publication number
RU2496787C2
RU2496787C2 RU2010154101/04A RU2010154101A RU2496787C2 RU 2496787 C2 RU2496787 C2 RU 2496787C2 RU 2010154101/04 A RU2010154101/04 A RU 2010154101/04A RU 2010154101 A RU2010154101 A RU 2010154101A RU 2496787 C2 RU2496787 C2 RU 2496787C2
Authority
RU
Russia
Prior art keywords
peptides
peptide
present
ctl
amino acid
Prior art date
Application number
RU2010154101/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2010154101A (ru
Inventor
Такуя Цунода
Рюдзи ОХСАВА
Original Assignee
Онкотерапи Сайенс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Онкотерапи Сайенс, Инк. filed Critical Онкотерапи Сайенс, Инк.
Publication of RU2010154101A publication Critical patent/RU2010154101A/ru
Application granted granted Critical
Publication of RU2496787C2 publication Critical patent/RU2496787C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2010154101/04A 2008-06-10 2009-06-09 Пептиды эпитопов mybl2 и содержащие их вакцины RU2496787C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6029308P 2008-06-10 2008-06-10
US61/060,293 2008-06-10
PCT/JP2009/002587 WO2009150822A1 (en) 2008-06-10 2009-06-09 Mybl2 epitope peptides and vaccines containing the same

Publications (2)

Publication Number Publication Date
RU2010154101A RU2010154101A (ru) 2012-07-20
RU2496787C2 true RU2496787C2 (ru) 2013-10-27

Family

ID=41416535

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010154101/04A RU2496787C2 (ru) 2008-06-10 2009-06-09 Пептиды эпитопов mybl2 и содержащие их вакцины

Country Status (13)

Country Link
US (1) US20110189213A1 (enExample)
EP (1) EP2297180A4 (enExample)
JP (1) JP2011522777A (enExample)
KR (1) KR20110016952A (enExample)
CN (1) CN102119170A (enExample)
AU (1) AU2009258775B2 (enExample)
BR (1) BRPI0913436A2 (enExample)
CA (1) CA2727482A1 (enExample)
IL (1) IL209870A0 (enExample)
MX (1) MX2010013688A (enExample)
RU (1) RU2496787C2 (enExample)
TW (1) TW201000119A (enExample)
WO (1) WO2009150822A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201200525A (en) * 2009-12-04 2012-01-01 Oncotherapy Science Inc MYBL2 peptides and vaccines containing the same
KR20140138900A (ko) 2012-03-09 2014-12-04 온코세라피 사이언스 가부시키가이샤 펩티드를 포함한 의약 조성물
CN104017054B (zh) * 2014-06-25 2016-12-07 南安市威速电子科技有限公司 Per2蛋白激动剂多肽及其应用
CN104004062B (zh) * 2014-06-25 2016-03-16 刘元超 关于per2蛋白激动剂多肽及其应用
CN104045693B (zh) * 2014-06-25 2016-12-07 杨高林 一种关于per2蛋白激动剂多肽及其应用
WO2017194170A1 (en) * 2016-05-13 2017-11-16 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
WO2017203370A2 (en) * 2016-05-23 2017-11-30 The Council Of The Queensland Institute Of Medical Research Cmv epitopes
CN109963862B (zh) * 2016-09-07 2024-01-30 武汉华大吉诺因生物科技有限公司 多肽及其应用
CN109136376B (zh) * 2018-05-21 2021-09-21 中国医科大学附属第四医院 一种膀胱癌相关环状RNA的应用和siRNA及其用途

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0253486A (ja) * 1988-08-19 1990-02-22 Rikagaku Kenkyusho ヒトｍｙｂ関連遺伝子
WO2003050140A1 (fr) * 2001-12-10 2003-06-19 Kyogo Itoh Antigenes tumoraux
WO2004018667A1 (ja) * 2002-08-26 2004-03-04 Kirin Beer Kabushiki Kaisha ペプチド及びこれを含む医薬
WO2004024766A1 (ja) * 2002-09-12 2004-03-25 Oncotherapy Science, Inc. Kdrペプチド及びこれを含むワクチン
WO2005100606A2 (en) * 2004-04-09 2005-10-27 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
JP2006014637A (ja) * 2004-06-30 2006-01-19 Kimimasa Yasumoto 癌特異的腫瘍抗原
WO2006028967A2 (en) * 2004-09-02 2006-03-16 Yale University Regulation of oncogenes by micrornas
US7026443B1 (en) * 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
WO2006037421A2 (en) * 2004-10-02 2006-04-13 Immatics Biotechnologies Gmbh Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
WO2006052731A2 (en) * 2004-11-05 2006-05-18 Genomic Health, Inc. Molecular indicators of breast cancer prognosis and prediction of treatment response
WO2006052862A1 (en) * 2004-11-05 2006-05-18 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
WO2007066423A1 (ja) * 2005-12-08 2007-06-14 Dainippon Sumitomo Pharma Co., Ltd. Ａｍａｃｒ由来の腫瘍抗原ペプチド
WO2007083806A1 (ja) * 2006-01-23 2007-07-26 Kurume University Ｃ型肝炎ウイルス２ａ由来ＨＬＡ－Ａ２拘束性抗原ペプチド
RU2455026C2 (ru) * 2005-06-17 2012-07-10 Имклоун Элэлси Антагонисты рецепторов для лечения метастатического рака

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1703522A (zh) * 2002-09-30 2005-11-30 肿瘤疗法科学股份有限公司 诊断睾丸精原细胞瘤的方法
US20050260639A1 (en) * 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
WO2007013671A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
EP2295571A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0253486A (ja) * 1988-08-19 1990-02-22 Rikagaku Kenkyusho ヒトｍｙｂ関連遺伝子
US7026443B1 (en) * 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
WO2003050140A1 (fr) * 2001-12-10 2003-06-19 Kyogo Itoh Antigenes tumoraux
WO2004018667A1 (ja) * 2002-08-26 2004-03-04 Kirin Beer Kabushiki Kaisha ペプチド及びこれを含む医薬
WO2004024766A1 (ja) * 2002-09-12 2004-03-25 Oncotherapy Science, Inc. Kdrペプチド及びこれを含むワクチン
WO2005100606A2 (en) * 2004-04-09 2005-10-27 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
JP2006014637A (ja) * 2004-06-30 2006-01-19 Kimimasa Yasumoto 癌特異的腫瘍抗原
WO2006028967A2 (en) * 2004-09-02 2006-03-16 Yale University Regulation of oncogenes by micrornas
WO2006037421A2 (en) * 2004-10-02 2006-04-13 Immatics Biotechnologies Gmbh Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
WO2006052731A2 (en) * 2004-11-05 2006-05-18 Genomic Health, Inc. Molecular indicators of breast cancer prognosis and prediction of treatment response
WO2006052862A1 (en) * 2004-11-05 2006-05-18 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
RU2455026C2 (ru) * 2005-06-17 2012-07-10 Имклоун Элэлси Антагонисты рецепторов для лечения метастатического рака
WO2007066423A1 (ja) * 2005-12-08 2007-06-14 Dainippon Sumitomo Pharma Co., Ltd. Ａｍａｃｒ由来の腫瘍抗原ペプチド
WO2007083806A1 (ja) * 2006-01-23 2007-07-26 Kurume University Ｃ型肝炎ウイルス２ａ由来ＨＬＡ－Ａ２拘束性抗原ペプチド

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
POWZANIUK,M.A. ET AL. 'B-Myb Overexpression Results in Activation and Increased Fas/Fas Ligand-Mediated Cytotoxicity of Т and NK Cells.' J IMMUNOL, v. 167, No. 1, 2001, p. 242-249. *
POWZANIUK,M.A. ET AL. 'B-Myb Overexpression Results in Activation and Increased Fas/Fas Ligand-Mediated Cytotoxicity of Т and NK Cells.' J IMMUNOL, v. 167, № 1, 2001, p. 242-249. *

Also Published As

Publication number Publication date
JP2011522777A (ja) 2011-08-04
US20110189213A1 (en) 2011-08-04
KR20110016952A (ko) 2011-02-18
TW201000119A (en) 2010-01-01
MX2010013688A (es) 2011-02-23
CN102119170A (zh) 2011-07-06
EP2297180A4 (en) 2011-11-09
CA2727482A1 (en) 2009-12-17
AU2009258775B2 (en) 2013-10-10
BRPI0913436A2 (pt) 2015-12-01
IL209870A0 (en) 2011-02-28
RU2010154101A (ru) 2012-07-20
AU2009258775A1 (en) 2009-12-17
EP2297180A1 (en) 2011-03-23
WO2009150822A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
US10711047B2 (en) CDCA1 epitope peptides and vaccines containing the same
WO2010021111A1 (en) Inhbb epitope peptides and vaccines containing the same
RU2498993C2 (ru) Пептиды тем8 и содержащие их вакцины
RU2496787C2 (ru) Пептиды эпитопов mybl2 и содержащие их вакцины
WO2010021112A1 (en) Hig2 and urlc10 epitope peptide and vaccines containing the same
US20140141028A1 (en) Melk epitope peptides and vaccines containing the same
HK1155757B (en) Cdca1 epitope peptides and vaccines containing the same
HK1155757A (en) Cdca1 epitope peptides and vaccines containing the same
HK1156341B (en) Melk epitope peptides and vaccines containing the same

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20150610